In expanded populations, comparing semaglutide versus sitagliptin for the composite outcome of myocardial infarction or stroke yielded a hazard ratio of 0.82 (95% confidence interval (CI) 0.74 to 0.91), and comparing tirzepatide versus dulaglutide for the composite outcome including mortality yielded a hazard ratio of 0.87 (95% CI 0.75 to 1.01)
Market Exclusions The scope excludes glucoselowering therapies that do not act via the GLP1 receptor (such as SGLT2 inhibitors, insulin, or DPP4 inhibitors), diagnostic tests, and devices
In the context of healthcare, potential wegovy interactions , particularly with medications such as Levothyroxine, must be considered
doi: 10.7326/AITC202406180 4 HammanRFBellRADabeleaDDAgostinoRBDolanLImperatoreGet al
Similarly, if these side effects continue to affect your daily life or get worse, a healthcare provider can help determine whether the symptoms are related to Ozempic or whether theres another cause